pharmacontrol lt phar acquire revco unit pharmacontrol corp say acquire private formulation inc lt revco inc six mln dlrs cash 13 550 000 dlr promissory note warrant buy 200 000 pharmacontrol common share pharmacontrol say purchase price finance along one mln dlrs work capital secure institutional finance company say betweenm 11 550 000 dlrs 12 550 000 dlrs f principal amount revco note plus accrue interest payable june 30 balance payable three year pharmacontrol say expect make payment due revco proceed propose offer unit consist convertible subordinate debenturers common stock currently file security exchange commission upon close public offer company say expect secure institutional finance increase total 12 mln dlrs private formulation primarily engage manufacture distribution vitamin private label counter pharmaceutical product 